Pharmacogenomics

Keyphrases

Publications

volume 25, number 1, 2024

Teresa T Ho, Janelle B Perkins, Rebecca Gonzalez, James Kevin Hicks, Ronald Alvarez Martinez, Katie Duranceau, Brianna North, Jongphil Kim, Jamie K Teer, Jiqiang Yao, Sean J Yoder, Taiga Nishihori, Nelli Bejanyan, Joseph Pidala, Hany Elmariah
Association between CYP3A4 , CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients. Pharmacogenomics 25 (1) (2024)
Victor Voicu, Nicolas Diehm, Igal Moarof, Sarah Parejo, Florent Badiqué, Andrea Burden, David Niedrig, Markus Béchir, Stefan Russmann
Antiplatelet therapy guided by CYP2C19 point-of-care pharmacogenetics plus multidimensional treatment decisions. Pharmacogenomics 25 (1) (2024)

volume 25, number 2, 2024

Georgia Ragia, Eirini Biziota, Triantafyllia Koukaki, Kyriakos Amarantidis, Vangelis G Manolopoulos
MIR27A rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of DPYD variations. Pharmacogenomics 25 (2) (2024)
Xueting Zhu, Guanghua Luo, Lu Zheng
Update on HLA-B*15:02 allele associated with adverse drug reactions. Pharmacogenomics 25 (2) (2024)
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, Konstantinos Koufou, George P Patrinos, Christina Mitropoulou
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications. Pharmacogenomics 25 (2) (2024)
Helena Pereira Ribeiro, Beatriz Meza Baraldi, Fernanda Rodrigues-Soares, Aline Cristiane Planello
Psychiatric Level 1A evidence pharmacogenomics in a Brazilian admixed cohort and global populations. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Georgia Ragia, Eirini Biziota, Triantafyllia Koukaki, Kyriakos Amarantidis, Vangelis G Manolopoulos
MIR27A rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of DPYD variations. Pharmacogenomics 25 (2) (2024)
Georgia Ragia, Eirini Biziota, Triantafyllia Koukaki, Kyriakos Amarantidis, Vangelis G Manolopoulos
MIR27A rs895819 TC genotype increases risk of fluoropyrimidine-induced severe toxicity independently of DPYD variations. Pharmacogenomics 25 (2) (2024)
Vasileios Fragoulakis, Margarita-Ioanna Koufaki, Korina Tzerefou, Konstantinos Koufou, George P Patrinos, Christina Mitropoulou
Assessing the utility of measurement methods applied in economic evaluations of pharmacogenomics applications. Pharmacogenomics 25 (2) (2024)
Xueting Zhu, Guanghua Luo, Lu Zheng
Update on HLA-B*15:02 allele associated with adverse drug reactions. Pharmacogenomics 25 (2) (2024)
Pedro Dorado, Eva M Peñas-Lledó
Pharmacogenetic and pharmacogenomic treatment of rheumatoid arthritis: a review of Pharmacogenomics Knowledge Base scientific evidence. Pharmacogenomics 25 (2) (2024)
Helena Pereira Ribeiro, Beatriz Meza Baraldi, Fernanda Rodrigues-Soares, Aline Cristiane Planello
Psychiatric Level 1A evidence pharmacogenomics in a Brazilian admixed cohort and global populations. Pharmacogenomics 25 (2) (2024)

volume 25, number 3, 2024

Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Rebekah Ryanne Wu, Richelle Benevent, Nina R Sperber, Jill S Bates, Daniel Villa, Dilhan Weeraratne, Timothy A Burrell, Deepak Voora
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration. Pharmacogenomics 25 (3) (2024)
Ambily Sivadas, Surabhi Rathore, S Sahana, Bani Jolly, Rahul C Bhoyar, Abhinav Jain, Vinod Scaria, Mohamed Imran, Vigneshwar Senthilvel, Mohit Kumar Divakar, Anushree Mishra, Sridhar Sivasubbu, Vinod Scaria
The genomic landscape of CYP2D6 variation in the Indian population. Pharmacogenomics 25 (3) (2024)
Ambily Sivadas, Surabhi Rathore, S Sahana, Bani Jolly, Rahul C Bhoyar, Abhinav Jain, Vinod Scaria, Mohamed Imran, Vigneshwar Senthilvel, Mohit Kumar Divakar, Anushree Mishra, Sridhar Sivasubbu, Vinod Scaria
The genomic landscape of CYP2D6 variation in the Indian population. Pharmacogenomics 25 (3) (2024)
Tarek Assi, Zamzam Tikriti, Annoir Shayya, Rebecca Ibrahim
Targeting RET mutation in medullary thyroid cancer. Pharmacogenomics 25 (3) (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Rebekah Ryanne Wu, Richelle Benevent, Nina R Sperber, Jill S Bates, Daniel Villa, Dilhan Weeraratne, Timothy A Burrell, Deepak Voora
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration. Pharmacogenomics 25 (3) (2024)
Tarek Assi, Zamzam Tikriti, Annoir Shayya, Rebecca Ibrahim
Targeting RET mutation in medullary thyroid cancer. Pharmacogenomics 25 (3) (2024)
Rebekah Ryanne Wu, Richelle Benevent, Nina R Sperber, Jill S Bates, Daniel Villa, Dilhan Weeraratne, Timothy A Burrell, Deepak Voora
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration. Pharmacogenomics 25 (3) (2024)
Rebekah Ryanne Wu, Richelle Benevent, Nina R Sperber, Jill S Bates, Daniel Villa, Dilhan Weeraratne, Timothy A Burrell, Deepak Voora
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration. Pharmacogenomics 25 (3) (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Francesco Pepe, Konstantinos Venetis, Giulia Cursano, Chiara Frascarelli, Pasquale Pisapia, Davide Vacirca, Claudia Scimone, Alessandra Rappa, Gianluca Russo, Eltjona Mane, Fabio Pagni, Isabella Castellano, Giancarlo Troncone, Carmine De Angelis, Giuseppe Curigliano, Elena Guerini-Rocco, Umberto Malapelle, Nicola Fusco
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories. Pharmacogenomics 25 (3) (2024)
Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal, Isabella Volkers, Juliet P Jacoby, Omer Berenfeld, Jasmine A Luzum
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study. Pharmacogenomics 25 (3) (2024)
Francesco Pepe, Konstantinos Venetis, Giulia Cursano, Chiara Frascarelli, Pasquale Pisapia, Davide Vacirca, Claudia Scimone, Alessandra Rappa, Gianluca Russo, Eltjona Mane, Fabio Pagni, Isabella Castellano, Giancarlo Troncone, Carmine De Angelis, Giuseppe Curigliano, Elena Guerini-Rocco, Umberto Malapelle, Nicola Fusco
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories. Pharmacogenomics 25 (3) (2024)

volume 25, number 4, 2024

Bani Jolly, Vinod Scaria
Ethnic differences in pharmacogenomic variants: a south Asian perspective. Pharmacogenomics 25 (4) (2024)
Guilherme Suarez-Kurtz, Claudio Jose Struchiner
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics 25 (4) (2024)
Abdullah Al Maruf, Meagan Shields, Amber Fryza, Amanda Wondrasek, Christine Leong, Kaarina Kowalec, Chad A Bousman
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada. Pharmacogenomics 25 (4) (2024)
Danyi Wang, Jayaprakasam Bolleddula, Anna Coenen-Stass, Thomas Grombacher, Jennifer Q Dong, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities. Pharmacogenomics 25 (4) (2024)
Bani Jolly, Vinod Scaria
Ethnic differences in pharmacogenomic variants: a south Asian perspective. Pharmacogenomics 25 (4) (2024)
Guilherme Suarez-Kurtz, Claudio Jose Struchiner
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics 25 (4) (2024)
Bani Jolly, Vinod Scaria
Ethnic differences in pharmacogenomic variants: a south Asian perspective. Pharmacogenomics 25 (4) (2024)
Danyi Wang, Jayaprakasam Bolleddula, Anna Coenen-Stass, Thomas Grombacher, Jennifer Q Dong, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities. Pharmacogenomics 25 (4) (2024)
Abdullah Al Maruf, Meagan Shields, Amber Fryza, Amanda Wondrasek, Christine Leong, Kaarina Kowalec, Chad A Bousman
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada. Pharmacogenomics 25 (4) (2024)
Yael Bar-Peled, Jessica J Denton, Jaimie L Richards, Donna Brown, Elizabeth A Worthey, Theresa V Strong
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization. Pharmacogenomics 25 (4) (2024)
Yael Bar-Peled, Jessica J Denton, Jaimie L Richards, Donna Brown, Elizabeth A Worthey, Theresa V Strong
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization. Pharmacogenomics 25 (4) (2024)
Guilherme Suarez-Kurtz, Claudio Jose Struchiner
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations. Pharmacogenomics 25 (4) (2024)

volume 25, number 5-6, 2024

Shufei Lai, Shaohong Luo, Qingwen Huang, Shen Lin, Xiaoting Huang, Honglin Xue, Yijun Cai, Xiongwei Xu, Xiuhua Weng
The cost-effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma. Pharmacogenomics 25 (5-6) (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics 25 (5-6) (2024)
Georgia Ragia, Myria Pallikarou, Yiota Manolopoulou, Theofanis Vorvolakos, Vangelis G Manolopoulos
Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation. Pharmacogenomics 25 (5-6) (2024)
Shih-Wei Lee, Pei-Tzu Chen, Chi-Wei Liu, Yuan-Hsu Li, Lawrence Shih-Hsin Wu
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity. Pharmacogenomics 25 (5-6) (2024)
Minhan Chen, Ying Liu, Weihua Xing
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma. Pharmacogenomics 25 (5-6) (2024)
Georgia Ragia, Myria Pallikarou, Yiota Manolopoulou, Theofanis Vorvolakos, Vangelis G Manolopoulos
Genetic diversity of cytochrome P450 in patients receiving psychiatric care in Greece: a step towards clinical implementation. Pharmacogenomics 25 (5-6) (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics 25 (5-6) (2024)
Shufei Lai, Shaohong Luo, Qingwen Huang, Shen Lin, Xiaoting Huang, Honglin Xue, Yijun Cai, Xiongwei Xu, Xiuhua Weng
The cost-effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma. Pharmacogenomics 25 (5-6) (2024)
Minhan Chen, Ying Liu, Weihua Xing
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma. Pharmacogenomics 25 (5-6) (2024)
Shih-Wei Lee, Pei-Tzu Chen, Chi-Wei Liu, Yuan-Hsu Li, Lawrence Shih-Hsin Wu
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity. Pharmacogenomics 25 (5-6) (2024)